Keros Therapeutics, Inc. (KROS) Headquarters — Lexington, Massachusetts

Headquarters

1050 Waltham Street
Suite 302
Lexington, MA 02421

Pending review

Exchange
Nasdaq
Sector
Medicine & Health
Industry
Pharmaceutical Preparations
Shares outstanding
19.83M (as of Jul 27, 2026)

Sector groupings are Tickerscape's own, derived from the company's SEC Standard Industrial Classification code — not GICS®, ICB® or any other licensed scheme, and they will disagree with those on some companies. How sectors are assigned.

Informational purposes only — not investment advice. Headquarters location reflects the company's most recently recorded principal address.